abexinostat
Showing 1 - 6 of 6
Non Hodgkin Lymphoma Trial in China (Abexinostat)
Recruiting
- Non Hodgkin Lymphoma
- Abexinostat
-
Beijing, China
- +3 more
Aug 18, 2022
Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in United States (Abexinostat, Ibrutinib)
Active, not recruiting
- Diffuse Large B-cell Lymphoma
- Mantle Cell Lymphoma
- Abexinostat
- Ibrutinib
-
Basking Ridge, New Jersey
- +6 more
Aug 11, 2022
Diffuse Large B-cell Lymphoma (DLBCL) Trial in China (abexinostat)
Recruiting
- Diffuse Large B-cell Lymphoma (DLBCL)
- abexinostat
-
Beijing, China
- +22 more
Jan 26, 2023
Lymphoma, Follicular Trial in China (Abexinostat)
Recruiting
- Lymphoma, Follicular
- Abexinostat
-
Beijing, China
- +25 more
Mar 3, 2022
Follicular Lymphoma Trial in France, Spain, United States (Abexinostat)
Active, not recruiting
- Follicular Lymphoma
- Abexinostat
-
Park Ridge, Illinois
- +14 more
May 10, 2021